GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Xianju Pharmaceutical Co Ltd (SZSE:002332) » Definitions » Debt-to-Asset

Zhejiang Xianju Pharmaceutical Co (SZSE:002332) Debt-to-Asset : 0.01 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Zhejiang Xianju Pharmaceutical Co Debt-to-Asset?

Zhejiang Xianju Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥28 Mil. Zhejiang Xianju Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥36 Mil. Zhejiang Xianju Pharmaceutical Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2025 was ¥7,129 Mil. Zhejiang Xianju Pharmaceutical Co's debt to asset for the quarter that ended in Mar. 2025 was 0.01.


Zhejiang Xianju Pharmaceutical Co Debt-to-Asset Historical Data

The historical data trend for Zhejiang Xianju Pharmaceutical Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Xianju Pharmaceutical Co Debt-to-Asset Chart

Zhejiang Xianju Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.11 0.05 0.03 0.01

Zhejiang Xianju Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.02 0.01 0.01

Competitive Comparison of Zhejiang Xianju Pharmaceutical Co's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Xianju Pharmaceutical Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Xianju Pharmaceutical Co's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Xianju Pharmaceutical Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Zhejiang Xianju Pharmaceutical Co's Debt-to-Asset falls into.


;
;

Zhejiang Xianju Pharmaceutical Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Zhejiang Xianju Pharmaceutical Co's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(28.173 + 30.78) / 6999.589
=0.01

Zhejiang Xianju Pharmaceutical Co's Debt-to-Asset for the quarter that ended in Mar. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(27.654 + 35.696) / 7128.642
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Xianju Pharmaceutical Co  (SZSE:002332) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Zhejiang Xianju Pharmaceutical Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Zhejiang Xianju Pharmaceutical Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Xianju Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Xianyue Road, Xianju County, Zhejiang Province, CHN, 317300
Zhejiang Xianju Pharmaceutical Co Ltd is a China-based company engaged in the production and sale of drugs. It mainly produces corticosteroids, sex hormones (gynecology and family planning drugs) and anesthesia and muscle relaxants.
Executives
Zhang Yu Song Directors, executives
Chen Wei Ping Securities Affairs Representative
Chen Jie Executives
Jin Jing De Director
Ying Ming Hua Executives
Lu Huan Xing Supervisors
Zheng Bi Jun Supervisors
Zhang Chi Supervisors
Zhang Qi Executives

Zhejiang Xianju Pharmaceutical Co Headlines

No Headlines